Form 4 for BCRX BIOCRYST PHARMACEUTICALS INC
Accepted 2026-06-15 16:16:15 ET · period of report 2026-06-11 · accession 0000882796-26-000045 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-15 16:16 | 2026-06-11 | BCRX | Frank Steven | Dir | A - Grant | $0.00 | +15.3K | 35.5K | +76% | $0 |
| D | 2026-06-15 16:16 | 2026-06-11 | BCRX | Frank Steven | Dir | A - Grant | $0.00 | +33.5K | 33.5K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-11 | A | A | 15,294 | $0.00 | 35,459 | D | — | — | (F1) Automatic non-employee director grant of Restricted Stock Units pursuant to the BioCryst Pharmaceuticals, Inc. Non-Employee Director Compensation Policy, as amended (the "Director Compensation Policy"), which will vest on the first anniversary of the date of grant. |
| 2 | Derivative | Automatic Stock Option Grant | 2026-06-11 | A | A | 33,540 | $0.00 | 33,540 | D | $8.50 · 2027-06-11 to 2036-06-11 | 33,540 Common Stock | (F2) Automatic non-employee director grant of stock options pursuant to the Director Compensation Policy. |